HHC ACO Inc., an Accountable Care Organization | NYC Health + Hospitals

HHC ACO Inc., an Accountable Care Organization

ACO Name and Location

HHC ACO Inc
199 Water Street, 31st Floor
New York, New York 10038

ACO Primary Contact

Primary Contact Name Lana Vardanian, MD
Primary Contact Phone Number 212-788-3393
Primary Contact Email Address

Organizational Information

ACO participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
New York City Health and Hospitals Corporation Y
Brightpoint Health Y
Community Healthcare Network, Inc. Y
Coney Island Medical Practice Plan, P.C. Y
Downtown Bronx Medical Associates, P.C. Y
Harlem Medical Associates, P.C. Y
Metropolitan Medical Practice Plan, P.C. Y
Mount Sinai Elmhurst Faculty Practice Group Y
University Physicians of Brooklyn Y

ACO governing body:

Member
Last Name First Name Title/Position
Member’s Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable
Katz Mitchell Chair
1 ACO Participant Representative New York City Health and Hospitals Corporation
Chokshi Dave CEO
1 ACO Participant Representative New York City Health and Hospitals Corporation
Anantharam Plachikkat Treasurer
1 ACO Participant Representative New York City Health and Hospitals Corporation
Rocha, Jr. Israel Secretary
1 ACO Participant Representative New York City Health and Hospitals Corporation
Seigel Warren Voting Member
1 ACO Participant Representative Downtown Bronx Medical Associates, P.C.
Berger-Gaskin Jeromane Voting Member
1 Medicare Beneficiary Representative  
Foley William T Voting Member
1 ACO Participant Representative New York City Health and Hospitals Corporation
Diamond Jessica Voting Member
1 ACO Participant Representative Brightpoint Health
Kalkut Gary Voting Member
1 ACO Participant Representative New York City Health and Hospitals Corporation
Marcos Luis Voting Member
1 Other  
Moshirpur Jasmin Voting Member
1 ACO Participant Representative Mt. Sinai Elmhurst Faculty Practice Group

Key ACO clinical and administrative leadership:

Dave Chokshi, MD ACO Executive
Lana Vardanian, MD Medical Director
Catherine Patsos, Esq. Compliance Officer
Lana Vardanian, MD

Associated committees and committee leadership:

Committee Name Committee Leader Name and Position
Governance Committee Mitchell Katz, MD, Board Chair
Clinical Leadership & Quality Assurance Committee Lana Vardanian, MD, Medical Director
Audit Committee Vacant

Types of ACO participants, or combinations of participants, that formed the ACO:

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Federally Qualified Health Center (FQHC)
  • Electing Teaching Amendment (ETA) hospital

Shared Savings and Losses

Amount of Shared Savings/Losses

  • Second Agreement Period
  • Performance Year 2016, $1,586,859
  • First Agreement Period
  • Performance Year 2015, $6,052,364
  • Performance Year 2014, $2,644,605
  • Performance Year 2013, $3,639,766

Shared Savings Distribution

  • Second Agreement Period
  • Performance Year 2016
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 85%
  • Proportion of distribution to ACO participants: 15%
  • First Agreement Period
  • Performance Year 2015
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 20%
  • Proportion of distribution to ACO participants: 80%
  • Performance Year 2014
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 28%
  • Proportion of distribution to ACO participants: 72%
  • Performance Year 2013
  • Proportion invested in infrastructure: 0%
  • Proportion invested in redesigned care processes/resources: 36%
  • Proportion of distribution to ACO participants: 64%

Quality Performance Results

2016 Quality Performance Results:

Measure number Measure Name ACO performance Rate Mean performance rate (SSP-ACOs)
ACO #1 CAHPS: Getting Timely Care, Appointments, and Information 64.76 79.9
ACO #2 CAHPS: How Well Your Providers Communicate 87.51 92.63
ACO #3 CAHPS: Patients’ Rating of Provider 89.75 91.93
ACO #4 CAHPS: Access to Specialists 77.14 83.52
ACO #5 CAHPS: Health Promotion and Education 59.13 60
ACO #6 CAHPS: Shared Decision Making 70.47 75.28
ACO #7 CAHPS: Health Status/Functional Status 66.31 71.82
ACO #34 CAHPS: Stewardship of Patient Resources 15.97 27.52
ACO #8 Risk-Standardized, All Condition Readmission 15.82 14.7
ACO #35 Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM) 18.13 18.17
ACO #36 All-Cause Unplanned Admissions for Patients with DiabetesRa 55.24 53.2
ACO #37 All-Cause Unplanned Admissions for Patients with Heart Failure 87.71 75.23
ACO #38 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 71.26 59.81
ACO #9 Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5) 18.86 9.27
ACO #10 Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 ) 20.87 14.53
ACO #11 Percent of PCPs who Successfully Meet Meaningful Use Requirements 100 82.72
ACO #39 Documentation of Current Medications in the Medical Record 52.25 87.54
ACO #13 Falls: Screening for Future Fall Risk 69.69 64.04
ACO #14 Preventive Care and Screening: Influenza Immunization 77.78 68.32
ACO #15 Pneumonia Vaccination Status for Older Adults 83.66 69.21
ACO #16 Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up 78.85 74.45
ACO #17 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 96.44 90.98
ACO #18 Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 83.98 53.63
ACO #19 Colorectal Cancer Screening 66.26 61.52
ACO #20 Breast Cancer Screening 73.82 67.61
ACO #21 Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented 87.93 76.84
ACO #42 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 84.31 77.72
ACO #27 Diabetes Mellitus: Hemoglobin A1c Poor Control 16.91 18.24
ACO #41 Diabetes: Eye Exam 55.1 44.94
ACO #28 Hypertension (HTN): Controlling High Blood Pressure 69.91 70.52
ACO #30 Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 90.75 85.05
ACO #31 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) 95.45 88.67
ACO #33 Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) 90.35 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “HHC ACO Inc” to view the quality performance results. This ACO can also be found by using the ACO ID A00934 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.

WE ALWAYS PUT PATIENTS FIRST